Differential Diagnosis - Pacific University
Differential Diagnosis - Pacific University
Differential Diagnosis - Pacific University
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5/29/2012<br />
PGs and uveitis<br />
Study No. of eyes Time Uveitic response<br />
Warwar 1998 163 normals 1 year 6.4%<br />
Smith 1999 505 normals 1 year 1.0%<br />
Smith 1999 13 uveitics 1 year 23.1% Mostly mild cases<br />
Chang 2008 163 uveitics 3 mos.<br />
Markomichelakis<br />
2008 58 uveitics 6 mos.<br />
equal to<br />
control<br />
equal to<br />
control<br />
Control = fellow eye, non PG<br />
glaucoma medication<br />
Control =<br />
dorzolamide/timolol<br />
medication<br />
PGs and uveitis<br />
• Case studies describe patients in whom<br />
uveitis occurs in the ipsilaterally treated<br />
eye, and patients in whom the uveitis<br />
improves after cessation and recurs after<br />
rechallenge.<br />
• Latanoprost may not lower IOP during a<br />
uveitic flare.<br />
Goldberg 2008 5,856 normals 5 years OD<br />
laser burns OS peripheral retina, no tear<br />
Case #2: HF<br />
• Assessment: herpes simplex keratitis OS.<br />
• Plan: Rx Viroptic q2h OS, acyclovir<br />
400mg bid po, and erythromycin ung qhs<br />
OS.<br />
Case #2: HF<br />
Date VA OS Assessment Current medications<br />
10/25/07 20/200 Acute HSK OS TravatanZ qhs OU, timolol 0.5%<br />
GFSqam OU (continued)<br />
10/29/07 20/200 “Improving” Viroptic q2hr OS, erythromycin ung<br />
qhs OS (continued)<br />
11/02/07 20/200 “Improving” Viroptic 5x/day OS with taper,<br />
acyclovir 400 mg po bid<br />
11/09/07 4/300 “No improvement” Viroptic 5x/day OS, acyclovir 400mg<br />
po bid (continued)<br />
11/13/07 5/200-1 “Improving” Taper Viroptic over 4 days<br />
11/16/07 5/200-1 “Slowly improving” Viroptic qd x 2 days then d/c<br />
11/19/07 5/200- “Resolving” Refresh tears qid OS<br />
11/26/07 5/250 “Resolving” no change<br />
11/30/07 5/200 “no improvement” Replace erythro with bacitracin ung<br />
12/3/07 5/200- “Resolving” no change<br />
12/7/07 5/225 “Resolved” Replace baci with erythro ung qhs OU<br />
Case #2: HF<br />
Date VA OS Assessment Plan<br />
12/14/07 4/160 “Resolving” TravatanZ qhs OU, timolol 0.5% GFSqam<br />
OU, acyclovir 400 mg po bid (continued)<br />
12/31/07 4/160 “Resolving” no change<br />
2/5/08 5/700 Active disciform<br />
HSK<br />
Viroptic 5x/day OS,<br />
acyclovir 400 mg po bid (continued)<br />
2/8/08 2/125 “Resolving” Viroptic 5x.day OS<br />
2/11/08 2/125 “Resolving” Viroptid qid OS<br />
2/15/08 3/400 “Resolving” Viroptic qd OS x 1 day then d/c<br />
2/20/08 3/350 “Improving” D/c Viroptic. D/c TravatanZ OS<br />
2/25/08 3/350 “Improving” no change<br />
3/4/08 5/350 “improvement” D/c TravatanZ OD<br />
3/7/08 5/350 “continued<br />
no change<br />
improvement”<br />
3/14/08 5/300 “stable” no change<br />
Coursebook Page 39 of 139<br />
4